Mutations in human CDC73 (also called HRPT2) identified in cases of sporadic and hereditary parathyroid carcinomas appear to primarily be loss-of-function mutations including frameshifts, premature stop codons, and deletions that result in truncated proteins. This evidence concerns the gene CDC73 and parathyroid gland carcinoma.